Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more
Thermo Fisher Scientific Inc (TMO) - Total Assets
Latest total assets as of September 2025: $103.02 Billion USD
Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) holds total assets worth $103.02 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Thermo Fisher Scientific Inc - Total Assets Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Thermo Fisher Scientific Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Thermo Fisher Scientific Inc's total assets of $103.02 Billion consist of 22.8% current assets and 77.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.01 Billion | 4.1% |
| Accounts Receivable | $9.63 Billion | 9.9% |
| Inventory | $4.98 Billion | 5.1% |
| Property, Plant & Equipment | $10.79 Billion | 11.1% |
| Intangible Assets | $15.53 Billion | 16.0% |
| Goodwill | $45.85 Billion | 47.1% |
Asset Composition Trend (1985–2024)
This chart illustrates how Thermo Fisher Scientific Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Thermo Fisher Scientific Inc's current assets represent 22.8% of total assets in 2024, a decrease from 59.3% in 1985.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2024, down from 13.5% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 13.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 47.1% of total assets.
Thermo Fisher Scientific Inc Competitors by Total Assets
Key competitors of Thermo Fisher Scientific Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩42.32 Billion |
|
Bionet
TWO:1784
|
Taiwan | NT$3.10 Billion |
Thermo Fisher Scientific Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Thermo Fisher Scientific Inc generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Thermo Fisher Scientific Inc generates $6.51 in net profit.
Thermo Fisher Scientific Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.63 | 2.13 |
| Quick Ratio | 1.11 | 1.26 | 1.74 |
| Cash Ratio | 0.00 | 0.32 | 0.00 |
| Working Capital | $7.41 Billion | $ 9.18 Billion | $ 11.65 Billion |
Thermo Fisher Scientific Inc - Advanced Valuation Insights
This section examines the relationship between Thermo Fisher Scientific Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.32 |
| Latest Market Cap to Assets Ratio | 1.81 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | $97.32 Billion |
| Market Capitalization | $176.18 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Thermo Fisher Scientific Inc's assets above their book value (1.81 x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Thermo Fisher Scientific Inc's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Thermo Fisher Scientific Inc (1985–2024)
The table below shows the annual total assets of Thermo Fisher Scientific Inc from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $97.32 Billion | -1.42% |
| 2023-12-31 | $98.73 Billion | +1.62% |
| 2022-12-31 | $97.15 Billion | +2.14% |
| 2021-12-31 | $95.12 Billion | +37.76% |
| 2020-12-31 | $69.05 Billion | +18.28% |
| 2019-12-31 | $58.38 Billion | +3.82% |
| 2018-12-31 | $56.23 Billion | -0.77% |
| 2017-12-31 | $56.67 Billion | +23.44% |
| 2016-12-31 | $45.91 Billion | +12.43% |
| 2015-12-31 | $40.83 Billion | -4.71% |
| 2014-12-31 | $42.85 Billion | +34.49% |
| 2013-12-31 | $31.86 Billion | +16.10% |
| 2012-12-31 | $27.44 Billion | +2.28% |
| 2011-12-31 | $26.83 Billion | +25.47% |
| 2010-12-31 | $21.39 Billion | -0.99% |
| 2009-12-31 | $21.60 Billion | +2.42% |
| 2008-12-31 | $21.09 Billion | -0.55% |
| 2007-12-31 | $21.21 Billion | -0.26% |
| 2006-12-31 | $21.26 Billion | +400.10% |
| 2005-12-31 | $4.25 Billion | +18.87% |
| 2004-12-31 | $3.58 Billion | +5.54% |
| 2003-12-31 | $3.39 Billion | -7.08% |
| 2002-12-31 | $3.65 Billion | -4.65% |
| 2001-12-31 | $3.83 Billion | -21.34% |
| 2000-12-31 | $4.86 Billion | -6.15% |
| 1999-12-31 | $5.18 Billion | -18.16% |
| 1998-12-31 | $6.33 Billion | +9.24% |
| 1997-12-31 | $5.80 Billion | +12.73% |
| 1996-12-31 | $5.14 Billion | +37.29% |
| 1995-12-31 | $3.74 Billion | +24.01% |
| 1994-12-31 | $3.02 Billion | +22.08% |
| 1993-12-31 | $2.47 Billion | +36.04% |
| 1992-12-31 | $1.82 Billion | +51.59% |
| 1991-12-31 | $1.20 Billion | +33.54% |
| 1990-12-31 | $898.20 Million | +44.03% |
| 1989-12-31 | $623.60 Million | +27.24% |
| 1988-12-31 | $490.10 Million | +15.02% |
| 1987-12-31 | $426.10 Million | +37.94% |
| 1986-12-31 | $308.90 Million | +39.33% |
| 1985-12-31 | $221.70 Million | -- |